Arrhythmias & electrophysiology

Comparison of Extended Cryoballoon, Standard Cryoballoon, and Radiofrequency Catheter Ablation in Patients With Persistent Atrial Fibrillation (AF)

JACC Clin ElectrophysiolPublished Randomised controlled trial

Authors' conclusion

In patients with persistent AF, CB ablation was found to be as effective as RF ablation. The addition of posterior wall isolation using CB ablation did not improve the rhythm outcomes compared with standard CB ablation.

Study context

Population
Patients with persistent AF, 2 sites in South Korea
Participants
288 patients
Comparison
Extended cryoballoon (CB) vs standard CB vs radiofrequency (RF) ablation
Primary endpoint
Recurrence of atrial arrhythmia (AF or atrial tachycardia) after a 3-month blanking period, off antiarrhythmic drugs
Follow-up
12 months
Methodological detailsmulticentre, adjudicator-blinded, 3 arms
  • Multicentre
  • Adjudicator-blinded
  • 3 arms

Primary result

As reported in the abstract

Freedom from atrial arrhythmia recurrence

P = 0.787

Further findings

Freedom from atrial arrhythmia recurrence, regardless of antiarrhythmic drug use · 12 months

Similar across RF vs standard CB vs extended CB
51.5% vs 50.0% vs 49.1%; P = 0.924

Freedom from atrial arrhythmia recurrence after 1 or 2 procedures · 12 months

Similar across RF vs standard CB vs extended CB
57.9 vs 52.9% vs 52.2%; P = 0.945

Direct current cardioversion

No significant difference, RF vs standard CB vs extended CB
9.6% vs 10.2% vs 4.2%; P = 0.236

CV hospitalization

No significant difference, RF vs standard CB vs extended CB
3.2% vs 0% vs 2.1%; P = 0.170

Safety

Major adverse events

  • Major adverse events: P > 0.99

Original publication

Comparison of Extended Cryoballoon, Standard Cryoballoon, and Radiofrequency Catheter Ablation in Patients With Persistent AF. JACC Clin Electrophysiol. Published 1 September 2025. doi:10.1016/j.jacep.2025.08.003

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.